BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27322699)

  • 21. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
    Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
    Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
    Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
    Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database.
    Roman BR; Baxi SS; Cracchiolo JR; Blackwell TJ; Pfister DG; McBride S; Ganly I; Shah JP; Patel SG; Morris LG; Cohen MA
    J Surg Oncol; 2017 Sep; 116(3):351-358. PubMed ID: 28570758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study.
    Ferrandina G; Gambacorta A; Gallotta V; Smaniotto D; Fagotti A; Tagliaferri L; Foti E; Fanfani F; Autorino R; Scambia G; Valentini V
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):778-85. PubMed ID: 25585781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of histologic subtype in node-positive early-stage cervical cancer after hysterectomy and adjuvant radiotherapy.
    Zhou J; Zhang WW; Wu SG; He ZY; Sun JY; Yang GF; Li FY
    Int J Surg; 2017 Aug; 44():1-6. PubMed ID: 28583891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Chemoradiation Therapy for Cervical Cancer and Effect of Timing and Duration on Treatment Outcome.
    Jhawar S; Hathout L; Elshaikh MA; Beriwal S; Small W; Mahmoud O
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1132-1141. PubMed ID: 28721897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
    Li M; Hu M; Wang Y; Yang X
    Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():1-6. PubMed ID: 31082737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of chemoradiotherapy with and without brachytherapy as adjuvant therapy after radical surgery in early-stage cervical cancer with poor prognostic factors: An observational study.
    Lan ML; Yu X; Xiao H; Zhou P; Hu N; Liu Y; Wang G
    Medicine (Baltimore); 2017 Nov; 96(46):e8384. PubMed ID: 29145247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
    Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
    World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
    Zhao H; Li L; Su H; Lin B; Zhang X; Xue S; Fei Z; Zhao L; Pan Q; Jin X; Xie C
    Oncotarget; 2016 Oct; 7(43):70969-70978. PubMed ID: 27391158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
    Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
    Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between location of transposed ovary and function in cervical cancer patients who underwent radical hysterectomy.
    Yoon A; Lee YY; Park W; Huh SJ; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
    Int J Gynecol Cancer; 2015 May; 25(4):688-93. PubMed ID: 25675036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-hysterectomy cone biopsy is able to predict response in locally advanced cervical cancer patients submitted to neo-adjuvant chemoradiation.
    Fanfani F; Fagotti A; Gagliardi ML; Ferrandina G; Monterossi G; Gallotta V; Zannoni GF; Scambia G
    Eur J Surg Oncol; 2013 Sep; 39(9):1025-9. PubMed ID: 23827381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
    Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
    J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran.
    Behtash N; Karimi Zarchi M; Deldar M
    Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
    Guo Q; Wang R; Jin D; Yin Z; Hu B; Li R; Wu D
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):15-23. PubMed ID: 35181028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
    Trifiletti DM; Smith A; Mitra N; Grover S; Lukens JN; Cohen RB; Read P; Mendenhall WM; Lin A; Swisher-McClure S
    J Clin Oncol; 2017 May; 35(14):1550-1560. PubMed ID: 28475848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.